Insight Molecular Diagnostics Inc. (IMDX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Insight Molecular Diagnos...

NASDAQ: IMDX · Real-Time Price · USD
2.48
0.01 (0.40%)
At close: Sep 05, 2025, 3:55 PM
2.48
0.00%
After-hours: Sep 05, 2025, 04:10 PM EDT

Insight Molecular Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.88M 1.5M 958K 2.2M
Cost of Revenue
1.14M 1.09M 976K 7.54M
Gross Profit
740K 501K 78K 188K
Operating Income
-61.04M -25.14M -18M -23.77M
Interest Income
n/a n/a n/a n/a
Pretax Income
-60.66M -24.86M -18.61M -52.87M
Net Income
-60.66M -27.78M -72.9M -64.1M
Selling & General & Admin
13.79M 13.54M 23.01M 33.5M
Research & Development
9.84M 9.29M 7.3M 13.63M
Other Expenses
38.16M 2.81M -12.24M n/a
Operating Expenses
61.78M 25.64M 18.07M 47.13M
Interest Expense
84K 52K 83K 209K
Selling & Marketing Expenses
641K 2.79M 1.13M 11.17M
Cost & Expenses
62.92M 26.64M 18.95M 55.92M
Income Tax Expense
n/a n/a n/a -9.26M
Shares Outstanding (Basic)
13.07M 7.65M 5.54M 4.45M
Shares Outstanding (Diluted)
13.07M 7.65M 5.54M 4.45M
EPS (Basic)
-4.66 -3.75 -13.25 -14.42
EPS (Diluted)
-4.66 -3.75 -13.25 -14.42
EBITDA
-59.02M -23.12M -13.31M -48.46M
EBIT
-60.58M -24.8M -18.53M -52.66M
Depreciation & Amortization
1.56M 1.68M 5.22M 4.21M